A newly discovered Zika virus-specific synthetic molecule is capable of differentiating Zika-immune patient samples from samples of patients previously infected with the related dengue virus. The technology may lead to the development of better diagnostics and vaccine candidates, scientists announce in the Proceedings of the National Academy of Sciences.
Medical Xpress – latest medical and health news stories
